Laboratory Information Management System Market Size & Share Growth Forecast Report (2026-2035)

Laboratory Information Management System Market Overview

The global laboratory information management system market was valued at approximately USD 610 million in 2025 and is estimated to reach around USD 671 million in 2026, rising to roughly USD 1596 million by 2035, growing at approximately 10.10% CAGR from 2026 to 2035.

The market is backed by laboratory digitalization, increasing demands for electronic records and traceability, and the rising volume of scientific data. The U.S. Food and Drug Administration (FDA) continues to stress the need for the integrity, reliability, and availability of electronic records in regulated environments, promoting the need for controlled laboratory information systems.

The market witnesses an increase due to the rising adoption of laboratory automation, expanding pharmaceutical and biotechnology research, and the growing need for structured scientific data management. The National Institutes of Health (NIH) Data Management Sharing Policy mandates the applicable researchers to strategize for managing and sharing scientific data, further solidifying the need for organized and accessible laboratory information. The Bureau of Indian Standards also has their dedicated LIMS platform for recognized laboratories, signifying the continuous adoption of digital laboratory-management systems.

Research Methodology

The research utilizes secondary data from government agencies, regulatory authorities, scientific publications, company disclosure, laboratory-technology documentation, and industry data. The VynZ Research team scrutinizes market developments, laboratory digitalization, software adoption, deployment model, application requirements, end-user activity, and the regional situation to arrive at the market estimates for 2025 and a forecast for 2026 to 2035.

Research Highlights

• Services accounted for 52.80% in 2025 due to implementation, validation, integration, and support requirements.
• Broad-based LIMS represented 64.10% in 2025 because of cross-functional laboratory applicability.
• Cloud-based LIMS is projected to grow at 11.20% CAGR supported by scalability and accessibility.
• Pharmaceutical and biotechnology companies held 48.60% in 2025 owing to regulated laboratory workflows.
• North America accounted for 35.20% in 2025 due to pharmaceutical R&D and regulatory requirements.

Laboratory Information Management System Market Dynamics

Market Trends

The industry is witnessing growth trends toward cloud-based solutions, automation, instrument connectivity, and centralized laboratory data management. One of the key trends shaping the market is the movement toward integrated platforms connecting samples, instruments, workflows, results, and laboratory records. Recent scientific work on openBIS highlights the increasing importance of integrated data workflows and FAIR-oriented scientific data management in analytical laboratories. Another trend is the introduction of AI and advanced analytics into laboratory workflows. Vendors are increasingly including automated data handling, analytics, workflow monitoring, and structured data capabilities in LIMS platforms

Growth Drivers

The growth of the laboratory information management system market is being driven by increasing regulatory requirements around electronic records, audit trails, data integrity, and controlled information access. The FDA’s Part 11 guidance addresses electronic records and signatures and highlights factors such as validation, audit trails, record retention, and retrieval. These requirements encourage regulated laboratories to switch from fragmented manual processes to controlled digital systems. Additionally, rising scientific data volumes are playing a vital role in boosting adoption. The NIH Data Management and Sharing Policy require applicable research organizations to plan how scientific data and associated metadata will be managed and shared, highlighting the importance of a structured data-management infrastructure. LIMS platforms aid this requirement by centralizing sample information, results, metadata, and laboratory workflows.

Market Restraints / Challenges

While the market has positive growth prospects, it faces challenges in implementation complexity and validation requirements. Laboratories often have legacy instruments, customized workflows, and established databases, making migration and integration more challenging. FDA guidance suggests that computerized systems used in regulated activities may require risk-based consideration of validation and controls related to record integrity, adding to implementation requirements for regulated laboratories. Moreover, cybersecurity and data-management requirements pose operational challenges for laboratories. Connected instruments and cloud platforms increase the number of systems involved in laboratory data flows, requiring controlled access, secure interfaces, audit trails, and reliable data retention. Laboratories must maintain data quality and interoperability when transferring information between LIMS, instruments, electronic laboratory notebooks, and other enterprise systems.

Market Opportunities

The market has significant opportunities in cloud-based and SaaS LIMS, particularly among laboratories aiming at scalable infrastructure without extensive on-site IT requirements. Cloud platforms can centralize workflows, offer remote access, standardized configurations, and software updates. Another opportunity is investing in AI-enabled laboratory automation and advanced analytics. Increasing volumes of structured scientific data provide a basis for automated anomaly detection, workflow optimization, predictive analytics, and operational reporting. The NIH’s emphasis on effective data management and reuse encourages investment in systems capable of organizing scientific information in structured and accessible ways.

Global Laboratory Information Management System Market Report Coverage

Laboratory Information Management System Market Segmentation

By Component

Services accounted for approximately 52.80% of market revenue in 2025, supported by the implementation, validation, customization, integration, training, and ongoing maintenance requirements associated with LIMS deployment.

Software is expected to register approximately 10.60% CAGR from 2026 to 2035, due to cloud adoption, workflow automation, and subscription-based licensing.

By Product Type

Broad-based / multi-purpose LIMS accounted for approximately 64.10% of market revenue in 2025, driven by their applicability across research, quality control, manufacturing, environmental, food, and other laboratory environments.

Pharma-specific LIMS is projected to register approximately 10.80% CAGR from 2026 to 2035, for increasing requirements for regulated workflows, batch testing, stability management, data integrity, and traceability.

By Deployment Model

On-premise solutions accounted for approximately 49.20% of market revenue in 2025, reflecting the continued preference of large and highly regulated laboratories for direct infrastructure control, customized integrations, and localized data management.

Cloud-based LIMS is expected to register approximately 11.20% CAGR from 2026 to 2035, making it the fastest-growing deployment model. Growth is supported by scalable infrastructure, remote accessibility, subscription-based purchasing, and reduced requirements for local hardware management.

By End User

Pharmaceutical and biotechnology companies accounted for approximately 48.60% of market revenue in 2025, supported by extensive laboratory workflows, regulated research, quality-control activities, and growing volumes of scientific data.

Contract research and development organizations are projected to register approximately 10.90% CAGR from 2026 to 2035, due to increasing outsourcing of research and manufacturing activities and the need to manage sponsor-specific laboratory workflows.

Regional Insights

North America

North America accounted for approximately 35.20% of the laboratory information management system market in 2025, supported by extensive pharmaceutical and biotechnology research, mature laboratory informatics infrastructure, and strong regulatory requirements. The region is expected to maintain substantial demand as laboratories modernize legacy systems and expand electronic workflows. FDA requirements concerning electronic records, audit trails, and data integrity remain an important factor supporting adoption in regulated laboratory environments.

Europe

Europe represented approximately 20.40% of market revenue in 2025, supported by pharmaceutical research, biotechnology activity, quality-control laboratories, and continued laboratory digitalization. Demand is also supported by increasing emphasis on standardized scientific data and interoperable laboratory workflows. Research published in 2025 on FAIR-compliant laboratory data management demonstrated the practical importance of structured data platforms for analytical laboratory workflows.

Asia Pacific

Asia Pacific contributed approximately 19.80% of the global market in 2025 and is expected to record the fastest regional growth at approximately 11.70% CAGR from 2026 to 2035. Expansion of pharmaceutical manufacturing, biotechnology research, contract research services, and laboratory infrastructure is supporting adoption. India's Bureau of Indian Standards operates a LIMS platform covering recognized laboratories and maintains a large database of laboratory information, demonstrating the increasing institutional use of digital laboratory systems in the region.

Rest of World

Rest of World held the remaining 24.60% of market revenue in 2025, covering Latin America, the Middle East, and Africa. Adoption is supported by laboratory modernization, pharmaceutical manufacturing, food and environmental testing, and increasing digitalization of public and private laboratory operations.

Competitive Landscape / Company Insights

The laboratory information management system market is moderately competitive, with established providers focusing on cloud deployment, workflow automation, instrument integration, AI capabilities, and regulatory compliance. Companies are expanding SaaS offerings while developing specialized solutions for pharmaceutical, clinical, food, forensic, and research laboratories. LabVantage introduced new AI-driven capabilities in 2026, while LabWare expanded its SaaS portfolio in 2025. Siemens also continued developing LIMS functionality through its Opcenter Research Development and Laboratory platform.

Mini Profiles

Agilent Technologies develops SLIMS, combining LIMS and ELN functionality with sample tracking, laboratory workflow management, instrument integration, and data-integrity controls.

Benchling provides cloud-based laboratory information management capabilities focused on sample management, connected workflows, data integration, traceability, and modern life-science R&D.

LabVantage Solutions provides LIMS and laboratory informatics platforms covering workflow automation, data management, compliance, and increasingly AI-enabled laboratory operations.

Thermo Fisher Scientific provides SampleManager LIMS for laboratory workflow, sample management, instrument connectivity, data handling, and regulated laboratory operations. Its 2025 releases included updated SampleManager versions.

Waters Corporation provides NuGenesis LMS and related data-management capabilities covering sample management, laboratory workflows, scientific data, inventory, and compliance-oriented record management.

Key Players

• Agilent Technologies
• Autoscribe Informatics
• Benchling
• Illumina
• LabWare
• LabVantage Solutions
• Siemens
• STARLIMS
• Thermo Fisher Scientific
• Waters Corporation

Recent Developments

LabWare expanded its SaaS LIMS portfolio with LabWare ASSURE, adding a dedicated food-safety and quality solution alongside its existing SaaS offerings. The company positioned the platform around faster deployment, configurable workflows, compliance, and scalable laboratory operations.

STARLIMS continued expanding its laboratory informatics positioning in 2025, with its LIMS, ELN, and SDMS platforms receiving continued recognition in industry software evaluations. The company also continued emphasizing workflow automation, sample management, data integrity, and integrated laboratory operations.

Siemens released updates to its Opcenter Research Development and Laboratory platform, which integrates LIMS, electronic laboratory notebook, formulation, and specification-management functionality. The 2025 releases added workflow and calculation capabilities intended to reduce administrative effort and errors.

Thermo Fisher Scientific released SampleManager LIMS 21.3 SP1 in 2025, providing more than 70 defect fixes and strengthening core functionality and user experience. The release was also made available for SampleManager Cloud Hosted deployments.

Waters Corporation released NuGenesis LMS 9.4.0 in 2025 with security enhancements, Oracle database encryption support, improved inventory functions, granular permissions, and compatibility updates. The associated SDMS release also introduced security and audit-trail improvements.

Table of Contents for Laboratory Information Management System Market Report

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                  1.2.1.    By Component 
                  1.2.2.    By Product Type 
                  1.2.3.    By Deployment Model 
                  1.2.4.    By End User 
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                  1.5.1.  Data Sources
                             1.5.1.1. Primary Research
                             1.5.1.2. Secondary Research
                  1.5.2.  Methodology
                             1.5.2.1. Data Exploration
                             1.5.2.2. Forecast Parameters
                             1.5.2.3. Data Validation
                             1.5.2.4. Assumptions
                  1.5.3.  Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

       3.1.    Industry Dynamics
                 3.1.1.    Market Growth Drivers
                 3.1.2.    Market Restraints
                 3.1.3.    Key Market Trends
                 3.1.4.    Major Opportunities
       3.2.    Industry Ecosystem
                 3.2.1.    Porter’s Five Forces Analysis
                 3.2.2.    Recent Development Analysis
                 3.2.3.    Value Chain Analysis
       3.3.    Competitive Insight
                 3.3.1.    Competitive Position of Industry Players
                 3.3.2.    Market Attractive Analysis
                 3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

       4.1.    Global Market Overview
       4.2.    Global Market Estimate and Forecast to 2035

5.    Market Segmentation Estimate and Forecast

       5.1.    By Component 
                 5.1.1. Software
                           5.1.1.1. Market Definition
                           5.1.1.2. Market Estimation and Forecast to 2035
                 5.1.2. Services
                           5.1.2.1. Market Definition
                           5.1.2.2. Market Estimation and Forecast to 2035

       5.2.    By Product Type 
                 5.2.1. Broad-based / Multi-purpose LIMS
                           5.2.1.1. Market Definition
                           5.2.1.2. Market Estimation and Forecast to 2035
                 5.2.2. Pharma-specific LIMS
                           5.2.2.1. Market Definition
                           5.2.2.2. Market Estimation and Forecast to 2035

       5.3.    By Deployment Model 
                 5.3.1. On-premise
                           5.3.1.1. Market Definition
                           5.3.1.2. Market Estimation and Forecast to 2035
                 5.3.2. Web-hosted
                           5.3.2.1. Market Definition
                           5.3.2.2. Market Estimation and Forecast to 2035
                 5.3.3. Cloud-based
                           5.3.3.1. Market Definition
                           5.3.3.2. Market Estimation and Forecast to 2035

       5.4.    By End User 
                 5.4.1. Pharmaceutical and Biotechnology Companies
                           5.4.1.1. Market Definition
                           5.4.1.2. Market Estimation and Forecast to 2035
                 5.4.2. Contract Research / Development and Manufacturing Organizations
                           5.4.2.1. Market Definition
                           5.4.2.2. Market Estimation and Forecast to 2035
                 5.4.3. Academic Medical and Research Institutes
                           5.4.3.1. Market Definition
                           5.4.3.2. Market Estimation and Forecast to 2035
                 5.4.4. Hospital and Clinical Diagnostic Laboratories
                           5.4.4.1. Market Definition
                           5.4.4.2. Market Estimation and Forecast to 2035

6.   North America Market Estimate and Forecast

      6.1.    By Component   
      6.2.    By Product Type   
      6.3.    By Deployment Model   
      6.4.    By End User   
                6.4.1.     U.S. Market Estimate and Forecast
                6.4.2.     Canada Market Estimate and Forecast
                6.4.3.     Mexico Market Estimate and Forecast

7.   Europe Market Estimate and Forecast

      7.1.    By Component   
      7.2.    By Product Type   
      7.3.    By Deployment Model   
      7.4.    By End User   
                7.4.1.     Germany Market Estimate and Forecast
                7.4.2.     France Market Estimate and Forecast
                7.4.3.     U.K. Market Estimate and Forecast
                7.4.4.     Italy Market Estimate and Forecast
                7.4.5.     Spain Market Estimate and Forecast
                7.4.6.     Russia Market Estimate and Forecast
                7.4.7.     Rest of Europe Market Estimate and Forecast

8.   Asia-Pacific (APAC) Market Estimate and Forecast

      8.1.    By Component   
      8.2.    By Product Type   
      8.3.    By Deployment Model   
      8.4.    By End User   
                8.4.1.     China Market Estimate and Forecast
                8.4.2.     Japan Market Estimate and Forecast
                8.4.3.     India Market Estimate and Forecast
                8.4.4.     South Korea Market Estimate and Forecast
                8.4.5.     Rest of Asia-Pacific Market Estimate and Forecast

9.   Rest of the World (RoW) Market Estimate and Forecast

      9.1.    By Component   
      9.2.    By Product Type   
      9.3.    By Deployment Model   
      9.4.    By End User   
                9.4.1.     Brazil Market Estimate and Forecast
                9.4.2.     Saudi Arabia Market Estimate and Forecast
                9.4.3.     South Africa Market Estimate and Forecast
                9.4.4.     U.A.E. Market Estimate and Forecast
                9.4.5.     Other Countries Market Estimate and Forecast

10.  Company Profiles

       10.1.   Agilent Technologies
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.2.   Autoscribe Informatics
                  10.2.1.    Snapshot
                  10.2.2.    Overview
                  10.2.3.    Offerings
                  10.2.4.    Financial Insight
                  10.2.5.    Recent Developments
       10.3.   Benchling
                  10.3.1.    Snapshot
                  10.3.2.    Overview
                  10.3.3.    Offerings
                  10.3.4.    Financial Insight
                  10.3.5.    Recent Developments
       10.4.   Illumina
                  10.4.1.    Snapshot
                  10.4.2.    Overview
                  10.4.3.    Offerings
                  10.4.4.    Financial Insight
                  10.4.5.    Recent Developments
       10.5.   LabWare
                  10.5.1.    Snapshot
                  10.5.2.    Overview
                  10.5.3.    Offerings
                  10.5.4.    Financial Insight
                  10.5.5.    Recent Developments
       10.6.   LabVantage Solutions
                  10.6.1.    Snapshot
                  10.6.2.    Overview
                  10.6.3.    Offerings
                  10.6.4.    Financial Insight
                  10.6.5.    Recent Developments
       10.7.   Siemens
                  10.7.1.    Snapshot
                  10.7.2.    Overview
                  10.7.3.    Offerings
                  10.7.4.    Financial Insight
                  10.7.5.    Recent Developments
       10.8.   STARLIMS
                  10.8.1.    Snapshot
                  10.8.2.    Overview
                  10.8.3.    Offerings
                  10.8.4.    Financial Insight
                  10.8.5.    Recent Developments
       10.9.   Thermo Fisher Scientific
                  10.9.1.    Snapshot
                  10.9.2.    Overview
                  10.9.3.    Offerings
                  10.9.4.    Financial Insight
                  10.9.5.    Recent Developments
       10.10.   Waters Corporation
                  10.10.1.    Snapshot
                  10.10.2.    Overview
                  10.10.3.    Offerings
                  10.10.4.    Financial Insight
                  10.10.5.    Recent Developments

11.    Appendix

         11.1.    Exchange Rates
         11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.